Advertisement

Topics

Medivir Initiates Clinical Study Of Birinapant In Combination With KEYTRUDA (Pembrolizumab) In Patients With Treatment-Refractory Solid Tumours

20:00 EDT 17 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Medivir Initiates Clinical Study Of Birinapant In Combination With KEYTRUDA (Pembrolizumab) In Patients With Treatment-Refractory Solid Tumours

NEXT ARTICLE

More From BioPortfolio on "Medivir Initiates Clinical Study Of Birinapant In Combination With KEYTRUDA (Pembrolizumab) In Patients With Treatment-Refractory Solid Tumours"

Advertisement
Quick Search
Advertisement
Advertisement